GlassScriptPhysician profile
Pulin A Shah
NPI 1770537128
$148,222.71
in general payments reported to CMS, 2019-2025
21 companies · $10K in 2025
The $10K reported for 2025 was more than what 93% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $3,390 · 2021: $24K · 2022: $37K · 2023: $6,794 · 2024: $4,285 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,900 · Food and Beverage: $4,367 · Travel and Lodging: $1,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,512.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,900.00 |
| Food and Beverage | $4,367.35 |
| Travel and Lodging | $1,672.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $102,663.43 | 2019-2025 | Tecnis Iol, Healon Duet Pro, Whitestar Signature |
| Alcon Vision LLC | $31,916.73 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Glaukos Corporation | $11,465.61 | 2019-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Photrexa Viscous and Photrexa |
| Carl Zeiss Meditec USA, INC. | $337.34 | 2021-2024 | Iolmaster 700 |
| Dompe US, INC. | $307.44 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $236.01 | 2021-2023 | Cequa |
| Omeros Corporation | $150.18 | 2019-2020 | |
| Genentech USA, INC. | $132.51 | 2022 | |
| Abbvie INC. | $132.13 | 2022 | |
| Mallinckrodt Hospital Products INC. | $124.99 | 2023 | Acthar |
| Allergan, INC. | $122.54 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $121.68 | 2025 | Xdemvy |
| Astellas Pharma US INC | $86.46 | 2023 | Izervay |
| Rxsight INC | $83.99 | 2021-2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Apellis Pharmaceuticals, INC. | $82.95 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Oyster Point Pharma, INC. | $60.65 | 2022-2024 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $53.91 | 2024 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
| Biotissue Holdings INC. | $34.12 | 2025 | |
| New World Medical,INC. | $24.86 | 2023 | |
| Eyevance Pharmaceuticals LLC | $20.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pulin Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.